Clinical trials: SCT
Self-compassion Training (SCT) Plus Intranasal Oxytocin, Self-compassion Training (SCT) Plus Intranasal Placebo
Oxytocin Plus Self-compassion Training in Borderline Personality Disorder
Background: Borderline personality disorder (BPD) is a frequentand serious psychiatric disorder characterized by a persistent pattern of instability in relationships, affect and self-image.
- Trial name
- NCT07551882
- Testing
- Intranasal Oxytocin (IN-OXT), Self-Compassion Training (SCT)
- Where
- Spain
- Volunteers
- 80 people
- Sponsor
- Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
MDS, SCT
Individual Molecular MRD Monitoring for MDS Patients After Allo-SCT
This study aims to develop highly sensitive methods for early detection of relapse based on the patients unique mutations. Initially, a mutational screen is being performed.
- Conditions
- MDS, SCT, MRD
- Trial name
- NCT02872662
- Where
- 8 sites in Denmark, Norway and 1 more
- Volunteers
- 308 people
- Sponsor
- Nordic MDS Group
Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS)/AML
Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS
This is an open-label, single-center, non-randomized phase I/II pilot study evaluating proton-based Total Marrow Irradiation (TMI) as part of the conditioning regimen prior to allogeneic hematopoietic stem cell transplantation…
- Conditions
- Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS)/AML, Proton Therapy, MDS and AML Prior to Allogeneic SCT
- Trial name
- UHKT-PTC-TMI-1 (NCT07532824)
- Testing
- Proton Total Marrow Irradiation
- Where
- 2 sites in Czechia
- Volunteers
- 16 people
- Sponsor
- Institute of Hematology and Blood Transfusion, Czech Republic
Acute Leukemia, Hematopoietic Stem Cell Transplantation (SCT)
Impact of Supportive Care on the Experience of Hospitalization of Patients Staying in the Protected Area of the Department of Blood Diseases
Patients with acute leukemia or received SCT are hospitalized in protected area, at least for 28 days. In this area, there is some rules like: controlled-visit, protective-clothing….so patient are in social and familial isolation…
- Conditions
- Acute Leukemia, Hematopoietic Stem Cell Transplantation (SCT), Aplasia
- Trial name
- ASTERIA (NCT03959007)
- Testing
- Aesthetic therapy sessions, Questionnaire
- Where
- France
- Volunteers
- 70 people
- Sponsor
- University Hospital, Lille
Philadelphia Positive Acute Lymphoblastic Leukemia, SCT
SCT in Ph Positive Acute Lymphoblastic Leukemia
This study includes a registry-based, nationwide analysis to describe the clinical outcome of adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) who underwent an allogeneic hematopoietic…
- Trial name
- NCT03821727
- Testing
- Hematopoietic Stem Cell Transplantation
- Where
- 2 sites in Italy
- Volunteers
- 441 people
- Sponsor
- CANDONI ANNA
Condition After Allogenic Peripheral Stem Cell Transplantation (SCT)
PhaseII,Open-label,Pilot Study Evaluating the Safety+Efficacy of Certican ® in the Prevention of Chronic Graft-versus-host Disease+Late Pulmonary Complications After Allogeneic Hematopoietic Cell Transplantation Blood
In this prospective study is to examine whether the use of everolimus in patients after allogeneic SCT as part of GVHD prophylaxis for a further review in clinical studies is appropriate.
- Trial name
- NCT01509560
- Testing
- Everolimus
- Where
- Germany
- Volunteers
- 21 people
- Sponsor
- Gesellschaft fur Medizinische Innovation - Hamatologie und Onkologie mbH
MDS and AML Prior to Allogeneic SCT
Assessment of Body, Liver and Labile Plasma Iron and Their Association With Outcome and Immunological Recovery in Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) Patients Undergoing Allogeneic Stem Cell Transplantation - ALLIVE (ALLogeneic Iron inVEstigators) Observational Trial
The ALLIVE (ALLogeneic Iron inVEstigators) trial aims at quantifying the extent and dynamic change of LPI occurrence during conditioning and at identifying LPI-predictive peri-transplant parameters.
- Trial name
- ALLIVE (NCT01746147)
- Testing
- No intervention and study treatment
- Where
- 5 sites in Germany
- Volunteers
- 134 people
- Sponsor
- GWT-TUD GmbH
Allo-SCT Patients, Adult Allo-SCT Survivor
Web-based Patient Education Program to Manage Side Effects of Allogeneic Stem Cell Transplant
The purpose of this study is to develop an interactive web-based patient education program to help educate patients about the increased risk of MS and its cardiac risk factors following allo-SCT and to inform and motivate…
- Trial name
- NCT02812082
- Testing
- web-based patient education, questionnaire
- Where
- United States
- Sponsor
- Memorial Sloan Kettering Cancer Center
Myeloablative Allo-SCT
Randomized, Prospective, Multicenter Study to Compare Enteral Nutrition to Parenteral Nutrition as Feeding Support in Patients Presenting Malignant Hemopathy Who Underwent an Allogeneic Hematopoietic Stem Cell Transplantation.
Myeloablative allogeneic hematopoetic stem cell transplantation (AHSCT) are prone to frequent secondary malnutrition to metabolic and digestive troubles due to conditioning regimen, treatments (antibiotics, immunosuppressive…
- Trial name
- NEPHA (NCT01955772)
- Testing
- Enteral nutrition alanyl-glutamin, Dipeptiven
- Where
- France
- Volunteers
- 240 people
- Sponsor
- University Hospital, Clermont-Ferrand
Allogeneic Haplo-Stem Cell Transplatation (SCT), Graft Versus Host Disease
A Study to Evaluate the Effect of ATG-F on Engraftment, Graft Versus Host Disease (GVHD) and Graft Versus Leukemia (GVL) Effect in Haplo-identical SCT
This study is planned to evaluated whether ATG is needed in haploidentical stem cell transplantation
- Trial name
- NCT00616954
- Testing
- ATG-F
- Where
- Israel
- Volunteers
- 50 people
- Sponsor
- Hadassah Medical Organization
Refractory Cytopenia of Childhood, Reduced Intensity Conditioning (RIC)
Serial Analysis of Chimerism in Patients With Refractory Cytopenia (RC) Transplanted With Reduced Intensity Conditioning (RIC)
This is a prospective, non-randomized multi-center multi-national study to evaluate the chimerism measured by STR and SNP in patients with hypoplastic RC and normal karyotype transplanted with a preparative regimen of reduced…
- Conditions
- Refractory Cytopenia of Childhood, Reduced Intensity Conditioning (RIC), Myelodysplastic Syndrome (MDS), Hematopoietic Stem Cell Transplantation (SCT)
- Trial name
- NCT00682799
- Where
- Germany
- Volunteers
- 112 people
- Sponsor
- Charlotte Niemeyer, MD
Allo-SCT
The Role of CK18F in Predicting Graft-Versus-Host Disease (GvHD)
Prospective, within-subject controlled study on multiple subject groups to evaluate the meaning of CK18-fragments in the diagnosis, biological activity and prognosis of graft-versus-host disease (GvHD).
- Trial name
- NCT00935324
- Where
- Germany
- Volunteers
- 120 people, healthy volunteers welcome
- Sponsor
- Heidelberg University